Clinical study randomizing up to 1,200 patients designed to help change guidelines in treating intermediate-risk Pulmonary Embolism (PE) patients globally
Clinical study randomizing up to 1,200 patients designed to help change guidelines in treating intermediate-risk Pulmonary Embolism (PE) patients globally.
IRVINE, Calif., Nov. 27, 2023 Inari Medical, Inc. a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced.
Inari Medical (NARI) Announces First Patient Enrollment in PEERLESS II Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Inari Medical, Inc. (NASDAQ:NARI – Get Free Report)’s stock price traded up 3.4% during trading on Monday . The company traded as high as $57.12 and last traded at $57.09. 113,484 shares were traded during trading, a decline of 85% from the average session volume of 774,641 shares. The stock had previously closed at $55.19. […]